Too bad these BS articles are allowed to be posted. I did not read it, but I doubt they discussed all of the proof that the company is not a scam - clinical trials, FDA awards, universities hosting studies, patent holdings, records of asset purchase for polymedix intellectual property, etc. I typically don't have much liquid cash, but luckily I had a bit and bought at 2.24, then at 2.10, then at 1.75. If it continues down I'll do some tax selling of some bad performers and rotate that money into CTIX. This isn't their first short attack they have had to recover from, it might not be their last, but recover they will - too much positive clinical developments, locked up outstanding shares, and cash on hand for this to do any lasting damage. We'll be back up in no time. Rest easy.